Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2005 Jun;11(6):791-3.
doi: 10.3201/eid1106.050471.

An emptying quiver: antimicrobial drugs and resistance

J Todd Weber  1 , Patrice Courvalin
Affiliations
Review

An emptying quiver: antimicrobial drugs and resistance

J Todd Weber et al. Emerg Infect Dis. 2005 Jun.
No abstract available

PubMed Disclaimer

Figures

Figure 1
Figure 1
Schematic representation of mechanisms of resistance to antimicrobial agents.
Figure 2
Figure 2
J. Todd Weber Dr. Weber is the director of the Office of Antimicrobial Resistance, National Center for Infectious Diseases, Centers for Disease Control and Prevention. He is responsible for coordinating antimicrobial resistance activities at CDC and co-chairs the federal Interagency Task Force on Antimicrobial Resistance. He works with other agencies, state governments, medical societies, and other public and private organizations to enhance antimicrobial resistance prevention and control, surveillance and response, applied research, and training.
Figure 3
Figure 3
Patrice Courvalin - Dr. Courvalin is professor and head of the Antibacterial Agents Unit, National Reference Center for Antibiotics, Institut Pasteur, Paris. He is a member of multiple committees and professional organizations in Europe and around the world and a prolific author on infectious diseases and antimicrobial resistance topics. He serves on the editorial board of several international journals, including Emerging Infectious Diseases.
See this image and copyright information in PMC

Similar articles

See all similar articles

Cited by

See all "Cited by" articles

References

    1. Fleming A. Penicillin. Nobel lecture, December 11, 1945. [cited 2005 Mar 25]. Available from http://nobelprize.org/medicine/laureates/1945/fleming-lecture.pdf
    1. Smolinski MS, Hamburg MA, Lederberg J, eds. Microbial threats to health: emergence, detection, and response. Washington: Institute of Medicine; 2003. p. 32 - PubMed
    1. Powers JH. Antimicrobial drug development—the past, the present, and the future. Clin Microbiol Infect. 2004;10(Suppl 4):23–31. 10.1111/j.1465-0691.2004.1007.x - DOI - PubMed
    1. Livermore DM. The need for new antibiotics. Clin Microbiol Infect. 2004;10(Suppl 4):1–9. 10.1111/j.1465-0691.2004.1004.x - DOI - PubMed
    1. Food and Drug Administration. Linezolid approval [cited 2005 Apr 5]. Available from http://www.fda.gov/cder/foi/appletter/2000/21130ltr.pdf

Substances

LinkOut - more resources